Dokter Tes Darah Penanda Tumor terbaik di luar negeri — Halaman 7

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Profesor Schoppmann mengepalai Unit Tumor Gastroesofageal di Rumah Sakit Umum Wina. Beliau berspesialisasi dalam perawatan bedah kanker lambung dan esofagus.

• Mengoordinasikan skrining tes darah penanda tumor untuk kanker gastrointestinal
• Menerbitkan lebih dari 240 artikel khusus di jurnal medis utama
• Memimpin pengujian fungsional bedah untuk mengevaluasi kinerja sistem pencernaan
• Sekretaris Jenderal Masyarakat Onkologi Bedah Austria
• Profesor Madya Bedah di Universitas Medis Wina

Dr. Choi Han Yong memimpin Departemen Urologi di Samsung Medical Center. Beliau berspesialisasi dalam mengidentifikasi kanker urologi melalui penilaian diagnostik tingkat lanjut.

• Memimpin sayap onkologi dan urologi di pusat medis ternama dunia
• Berfokus pada deteksi keganasan prostat dan kandung kemih
• Spesialis bedah onkologi dengan keahlian dalam hasil skrining laboratorium
• Mengintegrasikan temuan tes darah ke dalam perencanaan bedah yang dipersonalisasi

Profesor Park Jung-won adalah spesialis terkemuka Korea di bidang karsinoma hepatoseluler dengan pengalaman lebih dari 30 tahun. Beliau merupakan Direktur Liver and Liver Cancer Center serta Integrated Cancer Care Center di Rumah Sakit Myongji. Beliau memimpin penyusunan pedoman HCC pertama di Korea pada tahun 2003 dan telah mengawasi pembaruannya selama sekitar 20 tahun. Timnya memvalidasi radioterapi berkas proton untuk kanker hati, sebagaimana dipublikasikan dalam Journal of Hepatology. Beliau telah menulis lebih dari 200 makalah yang terindeks SCI. Beliau juga membantu memimpin uji klinis global, termasuk studi CheckMate 9DW tahun 2025, yang menunjukkan peningkatan hasil dengan nivolumab ditambah ipilimumab untuk HCC yang tidak dapat dioperasi.

MD/PhD, Seoul National University; Anggota, National Academy of Medicine of Korea; mantan Presiden, Korean Liver Cancer Association; Ketua, Korean HCC Guidelines Committee; penghargaan dari Perdana Menteri dan Menteri Kesehatan; Pfizer Medical Research Award dan Roche Oncology Academic Award.

Dr. Song Hwayeong adalah seorang gastroenterolog. Bidang fokusnya meliputi kanker gastrointestinal (lambung dan esofagus) dan endoskopi tingkat lanjut (gastroskopi, kolonoskopi, ESD, dan polipektomi). Dr. Song juga menangani penyakit pencernaan dan hati, termasuk GERD, gastritis, hepatitis, infeksi H. pylori, dan penyakit hati.

Dr. Song menyelesaikan fellowship di bidang Gastroenterologi di Inje University Ilsan Paik Hospital. Dr. Song pernah menjabat sebagai Profesor Klinis di Sekolah Tinggi Kedokteran Universitas Inje, Gachon, dan Inha. Dr. Song adalah Direktur Pusat Gastroenterologi di Rumah Sakit Naeun.

Akreditasi: anggota penuh Asosiasi Kedokteran Internal Korea, Masyarakat Endoskopi Gastrointestinal Korea, dan Asosiasi Gastroenterologi Korea. Anggota Komite Doping, WKBL.

Makalah terpilih: karsinoma hepatoseluler kriptogenik; sirosis bilier primer dengan sindrom tumpang tindih; terapi untuk hepatitis B kronis yang resisten terhadap lamivudin; dan clevudine pada sirosis terkait HBV.

Dr. Zulfu Sertkaya adalah profesor asosiasi dan androlog di Andro Expertise di Istanbul. Beliau memegang gelar FEBU dari Asosiasi Urologi Eropa. Dr. Sertkaya berfokus pada kesehatan pria, fungsi seksual, dan prosedur urologi estetika. Beliau merawat pasien di kliniknya dan melakukan operasi di rumah sakit afiliasi.

• Mendapatkan status Fellow of the European Board of Urology (FEBU).
• Spesialis dalam andrologi, kesehatan seksual pria, dan urologi estetika.
• Melakukan operasi implan penis dan varikokelektomi untuk infertilitas.
• Bekerja di klinik yang diakreditasi oleh Asosiasi Medis Turki.

Dr. Yilmaz Bilgic adalah ahli gastroenterologi di Rumah Sakit Medipol Acibadem District yang terakreditasi JCI di Istanbul. Beliau berspesialisasi dalam pengobatan penyakit Crohn, kolitis ulseratif, dan gangguan hati yang kompleks. Dr. Bilgic menyelesaikan pelatihan endoskopi khusus di Rumah Sakit Anam di Korea Selatan. Beliau juga menyelesaikan kursus pelatihan ERCP di Olympus Training Center di Jerman.

• Melakukan endoskopi diagnostik dan terapeutik, kolonoskopi, dan reseksi lambung.
• Mengobati kondisi gastrointestinal termasuk esofagus Barrett dan pankreatitis kronis.
• Pernah menjabat sebagai Asisten Kepala Dokter di Pusat Medis Turgut Ozal Universitas Inonu.
• Memiliki indeks-H 10 di Google Scholar untuk penelitiannya di bidang gastroenterologi.

Dr. Cemalettin Aydin adalah profesor bedah umum di Rumah Sakit Medipol Acibadem di Istanbul. Beliau berspesialisasi dalam bedah gastroenterologi dan prosedur penurunan berat badan yang kompleks. Beliau menyelesaikan fellowship bergengsi di bidang bedah gastroenterologi di Rumah Sakit Spesialisasi Tinggi Turki.

• Melakukan operasi bariatrik tingkat lanjut termasuk bypass lambung dan gastrektomi lengan.
• Menangani kondisi gastrointestinal yang kompleks seperti pankreatitis, penyakit Crohn, dan sirosis.
• Pakar dalam gastroplasti lengan endoskopi (ESG) dan bedah anti-refluks laparoskopi.
• Bekerja di Medipol Acibadem, fasilitas terakreditasi JCI yang menggunakan sistem robotik da Vinci.

Dr. Mehmet Besir Surme adalah ahli bedah saraf di Rumah Sakit Kota Eskişehir di Turki. Beliau berspesialisasi dalam bedah saraf pediatrik dan pengangkatan tumor otak yang kompleks. Dr. Surme menyelesaikan fellowship internasional dalam bedah saraf pediatrik di Roma, Italia. Beliau telah menulis publikasi ilmiah dengan lebih dari 40 sitasi di bidangnya.

• Melakukan kraniotomi, operasi shunt untuk hidrosefalus, dan pengangkatan kista otak.
• Menangani sindrom Arnold Chiari dan stenosis tulang belakang menggunakan teknik bedah.
• Ahli dalam stimulasi otak dalam untuk penyakit Parkinson dan stimulasi sumsum tulang belakang.
• Menggunakan cetakan cetak 3D untuk prosedur kranioplasti yang disesuaikan.

Dr. Gokhan Yilmaz adalah dokter bedah umum di Rumah Sakit Medipol University Pendik di Istanbul. Beliau memiliki spesialisasi dalam bedah kolorektal, gastrointestinal, dan bariatrik. Dr. Yilmaz sebelumnya menjabat sebagai Asisten Profesor di Universitas Medipol Istanbul. Beliau menempuh pelatihan di Rumah Sakit Pelatihan dan Penelitian Okmeydanı, sebuah institusi medis terkemuka di Turki.

• Melakukan prosedur kompleks seperti gastric sleeve, gastric bypass, dan balon lambung.
• Menangani kondisi termasuk hernia inguinalis, kista pankreas, dan penyakit fibrokistik payudara.
• Melakukan penelitian bedah dan melatih dokter bedah baru sebagai anggota fakultas universitas.
• Bekerja di fasilitas yang meraih 95,4 dari 96,4 poin untuk kualitas layanan kesehatan.

Dr. Rafail Ibayev adalah ahli bedah gastrointestinal di Rumah Sakit Erdem di Istanbul. Beliau adalah pelopor dalam bedah minimal invasif dan metabolik. Dr. Ibayev melakukan prosedur laparoskopi untuk penyakit lambung, usus, dan rektum. Beliau memiliki pengalaman luas dalam bedah manajemen berat badan, termasuk gastrektomi lengan dan bypass lambung. Dr. Ibayev juga menangani kondisi endokrin dan payudara menggunakan teknik onkoplastik.

• Mengkhususkan diri dalam bedah bariatrik dan peningkatan kesehatan metabolik.
• Melakukan operasi kompleks untuk tumor hati, lambung, dan kolorektal.
• Menggunakan teknik laparoskopi untuk mengurangi jaringan parut dan mempercepat pemulihan.
• Bekerja di Rumah Sakit Erdem, yang menangani 200.000 pasien setiap tahun.

Dr. Osman Aktas adalah dokter bedah umum di Rumah Sakit Internasional Avicenna di Istanbul. Beliau menyelesaikan pelatihan bedah laparoskopi di Jerman. Beliau memiliki spesialisasi dalam bedah onkologi dan metabolik. Dr. Aktas sebelumnya menjabat sebagai kepala dokter di beberapa rumah sakit militer terkemuka.

• Melakukan bedah kanker kompleks seperti prosedur Whipple dan reseksi kolorektal.
• Mengobati obesitas dan diabetes menggunakan teknik bedah metabolik.
• Menangani tumor dan obstruksi gastrointestinal melalui metode invasif minimal.
• Menggunakan terapi laser untuk pengobatan modern penyakit anal.

Dr. Tuncay Tas adalah ahli bedah urologi di Safe Urology Clinic di Istanbul. Beliau adalah salah satu dari lima dokter pertama di dunia yang mempublikasikan hasil aplikasi P-Shot. Dr. Tas berspesialisasi dalam onkologi urologi dan kesehatan seksual pria. Beliau menyelesaikan fellowship-nya di Universitas Heidelberg di Jerman. Praktiknya berfokus pada pengobatan regeneratif dan bedah robotik untuk kanker.

• Mengembangkan teknik bedah untuk pembesaran penis dengan sertifikasi dari Inggris.
• Memperkenalkan suntikan kombinasi PRP dan sel punca pada penis ke Turki.
• Melakukan prostatektomi robotik dan operasi penyelamatan ginjal.
• Anggota International Society for Stem Cells Applications.

Dr. Jaydeep Palep memimpin departemen bedah di HCG Manavata Cancer Centre. Beliau menggunakan teknik robotik dan invasif minimal untuk menangani kondisi gastrointestinal yang kompleks.

• Spesialis bedah gastrointestinal atas termasuk lambung, limpa, dan sistem bilier
• Menguasai bedah robotik selama pelatihan lanjutan di Italia untuk presisi bedah yang tinggi
• Mempertahankan rekam jejak keselamatan yang sesuai dengan standar global untuk kasus bedah kompleks
• Menerbitkan banyak artikel di jurnal internasional mengenai hasil bedah metabolik dan robotik
• Pembicara rutin di forum medis global mengenai teknik bedah gastrointestinal tingkat lanjut

Dokter adalah otoritas yang dihormati dalam bidang radiologi, radiologi intervensional, pengobatan obesitas, dan onkologi intervensional. Dedikasi mereka untuk meningkatkan perawatan pasien terbukti melalui berbagai kontribusi dalam literatur medis, yang secara signifikan mempengaruhi pemahaman dan pengobatan berbagai kondisi medis.<\/p>

Lulus dari Universitas Istanbul, Sekolah Kedokteran Cerrahpaşa, dokter menyelesaikan residensi dalam Radiologi dan fellowship dalam Radiologi Intervensional di Memorial Sloan Kettering Cancer Center. Penelitian mereka, yang diterbitkan dalam jurnal-jurnal terkemuka, mencakup topik seperti biopsi postmortem pasien COVID-19 dan pengobatan kanker inovatif.<\/p>

Dr. Rafet Eren adalah seorang hematolog di Rumah Sakit Universitas Biruni di Istanbul. Beliau berspesialisasi dalam pengobatan leukemia, limfoma, dan mieloma. Dr. Eren adalah seorang Associate Professor dengan sekitar 50 publikasi ilmiah di jurnal internasional. Beliau menerima Penghargaan Peneliti Muda dari Masyarakat Hematologi Turki.

• Melakukan transplantasi sumsum tulang dan transplantasi sel punca haploidentik.
• Menyediakan terapi sel CAR-T dan perawatan biologis untuk kanker darah.
• Anggota Masyarakat Hematologi Eropa dan Asosiasi Hematologi Turki.
• Bekerja di Rumah Sakit Universitas Biruni, fasilitas yang terakreditasi TEMOS di Turki.

Dokter lulus dari Sekolah Kedokteran Hacettepe pada tahun 1985 dan menjadi Spesialis Penyakit Dalam di Universitas Ege pada tahun 1990. Untuk memperdalam keahliannya, dokter tersebut mengambil spesialisasi dalam hematologi dan menyelesaikan gelar Ph.D. di Sekolah Kedokteran Mie Jepang pada tahun 1995. Pada tahun 1997, dokter tersebut telah maju menjadi Asisten Profesor dan kemudian Profesor Hematologi di Universitas Ege. Pada tahun 2003, dokter tersebut melanjutkan sebagai Profesor Hematologi di Universitas Teknik Karadeniz. Dengan lebih dari 65 artikel ilmiah, 112 makalah pertemuan, dan 34 presentasi konferensi, dokter tersebut diakui atas kontribusinya dalam hematologi dan transplantasi sumsum tulang.<\/p>

Dr. Siegbert Rossol adalah Fellow dari Dewan Gastroenterologi Eropa. Beliau memimpin layanan medis di Klinik Nordwest di Frankfurt, di mana tes darah penanda tumor mendukung diagnosis kanker.

• Menerima beasiswa bergengsi Alexander von Humboldt untuk penelitian medisnya
• Menyelesaikan pelatihan hepatologi tingkat lanjut di King's College School di London
• Memiliki spesialisasi dalam mengangkat jaringan kanker menggunakan metode invasif minimal EMR dan ESD
• Memegang gelar Master of Science dalam Manajemen Kesehatan dari universitas Mannheim dan Heidelberg
• Anggota Asosiasi Amerika untuk Studi Penyakit Hati

Profesor Eckhart Weidmann memimpin departemen hematologi di Klinik Nordwest. Beliau berspesialisasi dalam kelainan darah dan menggunakan tes darah penanda tumor untuk deteksi kanker.

• Memimpin sektor hematologi di pusat medis besar Jerman
• Berspesialisasi dalam pengobatan limfoma non-Hodgkin dan kanker darah lainnya
• Berfokus pada diagnostik presisi untuk kondisi terkait darah
• Berwenang untuk mempraktikkan kedokteran pada tingkat akademik tertinggi